Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia – A 3-year follow-up

Initiating long-acting injectable antipsychotics during acute admission for patients with schizophrenia – A 3-year follow-up

The debate on whether long-acting injectable antipsychotic (LAIA) medication is superior to oral medication, in preventing rehospitalization of patients with schizophrenia, remains inconclusive. We compared rehospitalization rates over 3 years following discharge from an acute admission, in which pa...

Full description

Bibliographic Details
Main Authors: Chen-Chung Liu, Jia-Chi Shan, Chih-Lin Chiang, Ming H. Hsieh, Chih-Min Liu, Yi-Ling Chien, Shao-Chien Chen, Tzung-Jeng Hwang
Format: Article
Language:English
Published: Elsevier 2015-06-01
Series:Journal of the Formosan Medical Association
Subjects:
compliance
long-acting injectable antipsychotic
rehospitalization
schizophrenia
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664613000569

Internet

http://www.sciencedirect.com/science/article/pii/S0929664613000569

Similar Items